Submitted by Anonymous (not verified) on 18 October 2023 - 15:55
Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Lipodystrophy, Familial Partial, Date of authorisation: 29/07/2018, Revision: 9, Status: Authorised
Source: